The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Implementing Pharmacogenomics in Europe: Design and Implementation Strategy of the Ubiquitous Pharmacogenomics Consortium
Open accessAbstract
Despite scientific and clinical advances in the field of pharmacogenomics (PGx), application into routine care remains limited. Opportunely, several implementation studies and programs have been initiated over recent years. This article presents an overview of these studies and identifies current research gaps. Importantly, one such gap is the undetermined collective clinical utility of implementing a panel of PGx‐markers into routine care, because the evidence base is currently limited to specific, individual drug‐gene pairs. The Ubiquitous Pharmacogenomics (U‐PGx) Consortium, which has been funded by the European Commission's Horizon‐2020 program, aims to address this unmet need. In a prospective, block‐randomized, controlled clinical study (PREemptive Pharmacogenomic testing for prevention of Adverse drug REactions [PREPARE]), pre‐emptive genotyping of a panel of clinically relevant PGx‐markers, for which guidelines are available, will be implemented across healthcare institutions in seven European countries. The impact on patient outcomes and cost‐effectiveness will be investigated. The program is unique in its multicenter, multigene, multidrug, multi‐ethnic, and multihealthcare system approach.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Path to Personalized Medicine
Hamburg, M. A., & Collins, F. S. (2010) · New England Journal of Medicine · doi:10.1056/nejmp1006304 · Cited by 1,970
HLA-B*5701 Screening for Hypersensitivity to Abacavir
Mallal, S., Phillips, E., Carosi, G., Molina, J.-M., Workman, C., Tomažič, J., Jägel-Guedes, E., Rugina, S., Kozyrev, O., Cid, J. F., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706135 · Cited by 1,835
CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network
Relling, M. V., & Klein, T. E. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2010.279 · Cited by 1,164
Pharmacogenetics: From Bench to Byte— An Update of Guidelines
Swen, J. J., Nijenhuis, M., de Boer, A., Grandia, L., Maitland-van der Zee, A. H., Mulder, H., Rongen, G. A. P. J. M., van Schaik, R. H. N., Schalekamp, T., Touw, D. J., et al. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.34 · Cited by 1,018
Self-citationHicks, J., Bishop, Jr., Sangkuhl, K., Müller, D., Ji, Y., Leckband, S., Leeder, J., Graham, R., Chiulli, D., LLerena, A., et al. (2015) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.147 · Cited by 998
Self-citationPharmacogenomics in the clinic
Relling, M. V., & Evans, W. E. (2015) · Nature · doi:10.1038/nature15817 · Cited by 904
Charting a course for genomic medicine from base pairs to bedside
National Human Genome Research Institute, Green, E. D., & Guyer, M. S. (2011) · Nature · doi:10.1038/nature09764 · Cited by 902
A Randomized Trial of Genotype-Guided Dosing of Warfarin
Pirmohamed, M., Burnside, G., Eriksson, N., Jorgensen, A. L., Toh, C. H., Nicholson, T., Kesteven, P., Christersson, C., Wahlström, B., Stafberg, C., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1311386 · Cited by 811
Self-citationBirdwell, K., Decker, B., Barbarino, J., Peterson, J., Stein, C., Sadee, W., Wang, D., Vinks, A., He, Y., Swen, J., et al. (2015) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.113 · Cited by 730
Self-citationCarbamazepine-Induced Toxic Effects and HLA-B*1502 Screening in Taiwan
Chen, P., Lin, J.-J., Lu, C.-S., Ong, C.-T., Hsieh, P. F., Yang, C.-C., Tai, C.-T., Wu, S.-L., Lu, C.-H., Hsu, Y.-C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009717 · Cited by 711
The Electronic Medical Records and Genomics (eMERGE) Network: past, present, and future
Gottesman, O., Kuivaniemi, H., Tromp, G., Faucett, W. A., Li, R., Manolio, T. A., Sanderson, S. C., Kannry, J., Zinberg, R., Basford, M. A., et al. (2013) · Genetics in Medicine · doi:10.1038/gim.2013.72 · Cited by 698
Johnson, J. A., Gong, L., Whirl-Carrillo, M., Gage, B. F., Scott, S. A., Stein, C. M., Anderson, J. L., Kimmel, S. E., Lee, M. T. M., Pirmohamed, M., et al. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.185 · Cited by 647
Self-citationPreemptive Clinical Pharmacogenetics Implementation: Current Programs in Five US Medical Centers
Dunnenberger, H. M., Crews, K. R., Hoffman, J. M., Caudle, K. E., Broeckel, U., Howard, S. C., Hunkler, R. J., Klein, T. E., Evans, W. E., & Relling, M. V. (2015) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010814-124835 · Cited by 511
Hicks, J. K., Swen, J. J., Thorn, C. F., Sangkuhl, K., Kharasch, E. D., Ellingrod, V. L., Skaar, T. C., Müller, D. J., Gaedigk, A., & Stingl, J. C. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.2 · Cited by 453
Self-citationPulley, J. M., Denny, J. C., Peterson, J. F., Bernard, G. R., Vnencak-Jones, C. L., Ramirez, A. H., Delaney, J. T., Bowton, E., Brothers, K., Johnson, K., et al. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.371 · Cited by 414
Crews, K. R., Gaedigk, A., Dunnenberger, H. M., Klein, T. E., Shen, D. D., Callaghan, J. T., Kharasch, E. D., & Skaar, T. C. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.287 · Cited by 371
Leckband, S. G., Kelsoe, J. R., Dunnenberger, H. M., George, A. L., Tran, E., Berger, R., Müller, D. J., Whirl-Carrillo, M., Caudle, K. E., & Pirmohamed, M. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.103 · Cited by 335
Self-citationClinically Actionable Genotypes Among 10,000 Patients With Preemptive Pharmacogenomic Testing
Van Driest, S., Shi, Y., Bowton, E., Schildcrout, J., Peterson, J., Pulley, J., Denny, J., & Roden, D. (2014) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.229 · Cited by 334
Wilke, R. A., Ramsey, L. B., Johnson, S. G., Maxwell, W. D., McLeod, H. L., Voora, D., Krauss, R. M., Roden, D. M., Feng, Q., Cooper-DeHoff, R. M., et al. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.57 · Cited by 332
Pharmacogenomics: bench to bedside
Weinshilboum, R., & Wang, L. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1497 · Cited by 320
Bielinski, S. J., Olson, J. E., Pathak, J., Weinshilboum, R. M., Wang, L., Lyke, K. J., Ryu, E., Targonski, P. V., Van Norstrand, M. D., Hathcock, M. A., et al. (2014) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2013.10.021 · Cited by 301
PG4KDS: A model for the clinical implementation of pre‐emptive pharmacogenetics
Hoffman, J. M., Haidar, C. E., Wilkinson, M. R., Crews, K. R., Baker, D. K., Kornegay, N. M., Yang, W., Pui, C., Reiss, U. M., Gaur, A. H., et al. (2014) · American Journal of Medical Genetics Part C: Seminars in Medical Genetics · doi:10.1002/ajmg.c.31391 · Cited by 276
Pharmacogenetics: From Bench to Byte
Swen, J. J., Wilting, I., de Goede, A., Grandia, L., Mulder, H., Touw, D. J., de Boer, A., Conemans, J. M. H., Egberts, T. C. G., Klungel, O. H., et al. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100507 · Cited by 269
Self-citationPatient-reported outcomes in the evaluation of toxicity of anticancer treatments
Di Maio, M., Basch, E., Bryce, J., & Perrone, F. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.222 · Cited by 251
Gammal, R. S., Court, M., Haidar, C. E., Iwuchukwu, O. F., Gaur, A. H., Alvarellos, M. L., Guillemette, C., Lennox, J., Whirl‐Carrillo, M., Brummel, S., et al. (2015) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.269 · Cited by 246
The IGNITE network: a model for genomic medicine implementation and research
on behalf of the IGNITE Network, Weitzel, K. W., Alexander, M., Bernhardt, B. A., Calman, N., Carey, D. J., Cavallari, L. H., Field, J. R., Hauser, D., Junkins, H. A., et al. (2015) · BMC Medical Genomics · doi:10.1186/s12920-015-0162-5 · Cited by 246
Caudle, K. E., Rettie, A. E., Whirl-Carrillo, M., Smith, L. H., Mintzer, S., Lee, M. T. M., Klein, T. E., & Callaghan, J. T. (2014) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2014.159 · Cited by 243
The Pharmacogenetics Research Network: From SNP Discovery to Clinical Drug Response
Giacomini, K. M., Brett, C. M., Altman, R. B., Benowitz, N. L., Dolan, M. E., Flockhart, D. A., Johnson, J. A., Hayes, D. F., Klein, T., Krauss, R. M., et al. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100087 · Cited by 242
Rasmussen-Torvik, L. J., Stallings, S. C., Gordon, A. S., Almoguera, B., Basford, M. A., Bielinski, S. J., Brautbar, A., Brilliant, M. H., Carrell, D. S., Connolly, J. J., et al. (2014) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2014.137 · Cited by 239
Kozyra, M., Ingelman-Sundberg, M., & Lauschke, V. M. (2017) · Genetics in Medicine · doi:10.1038/gim.2016.33 · Cited by 230
Self-citationA Randomized Trial of Genotype-Guided Dosing of Acenocoumarol and Phenprocoumon
Verhoef, T. I., Ragia, G., de Boer, A., Barallon, R., Kolovou, G., Kolovou, V., Konstantinides, S., Le Cessie, S., Maltezos, E., van der Meer, F. J. M., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1311388 · Cited by 226
Gallagher, R. M., Kirkham, J. J., Mason, J. R., Bird, K. A., Williamson, P. R., Nunn, A. J., Turner, M. A., Smyth, R. L., & Pirmohamed, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028096 · Cited by 218
Self-citationTranslating Pharmacogenomics: Challenges on the Road to the Clinic
Swen, J. J., Huizinga, T. W., Gelderblom, H., de Vries, E. G. E., Assendelft, W. J. J., Kirchheiner, J., & Guchelaar, H.-J. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040209 · Cited by 209
Self-citationKo, T.-M., Tsai, C.-Y., Chen, S.-Y., Chen, K.-S., Yu, K.-H., Chu, C.-S., Huang, C.-M., Wang, C.-R., Weng, C.-T., Yu, C.-L., et al. (2015) · BMJ · doi:10.1136/bmj.h4848 · Cited by 209
Development and use of active clinical decision support for preemptive pharmacogenomics
Bell, G. C., Crews, K. R., Wilkinson, M. R., Haidar, C. E., Hicks, J. K., Baker, D. K., Kornegay, N. M., Yang, W., Cross, S. J., Howard, S. C., et al. (2014) · Journal of the American Medical Informatics Association · doi:10.1136/amiajnl-2013-001993 · Cited by 208
Coenen, M. J. H., de Jong, D. J., van Marrewijk, C. J., Derijks, L. J. J., Vermeulen, S. H., Wong, D. R., Klungel, O. H., Verbeek, A. L. M., Hooymans, P. M., Peters, W. H. M., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.06.002 · Cited by 199
Self-citationShuldiner, A. R., Relling, M. V., Peterson, J. F., Hicks, K., Freimuth, R. R., Sadee, W., Pereira, N. L., Roden, D. M., Johnson, J. A., & Klein, T. E. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.59 · Cited by 190
O'Donnell, P. H., Bush, A., Spitz, J., Danahey, K., Saner, D., Das, S., Cox, N. J., & Ratain, M. J. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.117 · Cited by 180
Personalized Pharmacogenomics: Predicting Efficacy and Adverse Drug Reactions
Pirmohamed, M. (2014) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-090413-025419 · Cited by 169
Self-citationGottesman, O., Scott, S. A., Ellis, S. B., Overby, C. L., Ludtke, A., Hulot, J., Hall, J. L., Chatani, K., Myers, K., Kannry, J. L., et al. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.72 · Cited by 152
Genetic variation in the human cytochrome P450 supergene family
Fujikura, K., Ingelman‐Sundberg, M., & Lauschke, V. M. (2015) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0000000000000172 · Cited by 131
Self-citationO’Donnell, P. H., Danahey, K., Jacobs, M., Wadhwa, N. R., Yuen, S., Bush, A., Sacro, Y., Sorrentino, M. J., Siegler, M. A., Harper, W. R., et al. (2014) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.31385 · Cited by 127
Johnson, J. A., Burkley, B., Langaee, T. Y., Clare-Salzler, M. J., Klein, T. E., & Altman, R. B. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.125 · Cited by 112
Hoffman, J. M., Dunnenberger, H. M., Hicks, J. K., Caudle, K. E., Whirl‐Carrillo, M., Freimuth, R. R., Williams, M. S., Klein, T. E., & Peterson, J. F. (2016) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocw027 · Cited by 110
Basch, E., Rogak, L. J., & Dueck, A. C. (2016) · Clinical Therapeutics · doi:10.1016/j.clinthera.2016.03.011 · Cited by 105
Multidisciplinary model to implement pharmacogenomics at the point of care
Caraballo, P. J., Hodge, L. S., Bielinski, S. J., Stewart, A. K., Farrugia, G., Schultz, C. G., Vitek, C. R. R., Olson, J. E., Sauver, J. L. S., Roger, V. L., et al. (2016) · Genetics in Medicine · doi:10.1038/gim.2016.120 · Cited by 100
Muir, A. J., Gong, L., Johnson, S. G., Lee, M. T. M., Williams, M. S., Klein, T. E., Caudle, K. E., & Nelson, D. R. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.203 · Cited by 93
Johnson, J. A., Elsey, A. R., Clare-Salzler, M. J., Nessl, D. R., Conlon, M., & Nelson, D. R. (2013) · Pharmacogenomics · doi:10.2217/pgs.13.59 · Cited by 87
Clancy, J. P., Johnson, S. G., Yee, S. W., McDonagh, E. M., Caudle, K. E., Klein, T. E., Cannavo, M., & Giacomini, K. M. (2014) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2014.54 · Cited by 79
Physician Attitudes toward Adopting Genome-Guided Prescribing through Clinical Decision Support
Overby, C. L., Erwin, A., Abul‐Husn, N. S., Ellis, S. B., Scott, S. A., Obeng, A. O., Kannry, J. L., Hripcsak, G. M., Böttinger, E. P., & Gottesman, O. (2014) · Journal of Personalized Medicine · doi:10.3390/jpm4010035 · Cited by 62
Potential utility of precision medicine for older adults with polypharmacy: a case series study
Finkelstein, J., Friedman, C., Hripcsak, G. M., & Cabrera, M. R. (2016) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s101474 · Cited by 58
Targeted Next‐Generation Sequencing for Comprehensive Genetic Profiling of Pharmacogenes
Han, S.-J., Park, J. Y., Lee, J., Lee, S., Kim, H., Han, H. R., Kim, Y., Yi, S., Cho, J., Jang, I.-J., et al. (2016) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.532 · Cited by 55
Deverka, P. A., Doksum, T., & Carlson, R. J. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100319 · Cited by 52
Comparison of genome sequencing and clinical genotyping for pharmacogenes
Yang, W., Wu, G., Broeckel, U., Smith, C., Turner, V., Haidar, C. E., Wang, S., Carter, R., Karol, S. E., Neale, G. A. M., et al. (2016) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.411 · Cited by 52
Concordance of DMET Plus Genotyping Results With Those of Orthogonal Genotyping Methods
Fernandez, C. A., Smith, C. J., Yang, W., Lorier, R., Crews, K. R., Kornegay, N., Hicks, J. K., Stewart, C. F., Kawedia, J. D., Ramsey, L. B., et al. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.95 · Cited by 49
Transitioning Pharmacogenomics into the Clinical Setting: Training Future Pharmacists
Frick, A., Benton, C. S., Scolaro, K. L., McLaughlin, J. E., Bradley, C. L., Suzuki, O., Wang, N., & Wiltshire, T. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00241 · Cited by 44
Getting Pharmacogenomics Into the Clinic
Abbasi, J. (2016) · JAMA · doi:10.1001/jama.2016.12103 · Cited by 41
Blagec, K., Romagnoli, K. M., Boyce, R. D., & Samwald, M. (2016) · PeerJ · doi:10.7717/peerj.1671 · Cited by 37
Self-citationEconomic Evaluation of Pharmacogenetic Tests
Wu, A., & Fuhlbrigge, A. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2008.127 · Cited by 34
Personalized Medicine: Building the GPS to Take Us There
Ratain, M. J. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100092 · Cited by 28
Pharmacogenomically actionable medications in a safety net health care system
Carpenter, J. S., Rosenman, M. B., Knisely, M. R., Decker, B. S., Levy, K. D., & Flockhart, D. A. (2016) · SAGE Open Medicine · doi:10.1177/2050312115624333 · Cited by 27
Pharmacogenomics: will the promise be fulfilled?
Altman, R. B., Kroemer, H. K., McCarty, C. A., Ratain, M. J., & Roden, D. M. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2920 · Cited by 24
Cited by
Pharmacogenomics: current status and future perspectives
Pirmohamed, M. (2023) · Nature Reviews Genetics · doi:10.1038/s41576-022-00572-8 · Cited by 351
Self-citationA Review of the Important Role of CYP2D6 in Pharmacogenomics
Taylor, C., Crosby, I., Yip, V., Maguire, P., Pirmohamed, M., & Turner, R. M. (2020) · Genes · doi:10.3390/genes11111295 · Cited by 316
Self-citationVolpi, S., Bult, C. J., Chisholm, R. L., Deverka, P. A., Ginsburg, G. S., Jacob, H. J., Kasapi, M., McLeod, H. L., Roden, D. M., Williams, M. S., et al. (2018) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1048 · Cited by 135
Polypharmacy and precision medicine
Fujita, K., Masnoon, N., Mach, J., O’Donnell, L. K., & Hilmer, S. N. (2023) · Cambridge Prisms: Precision Medicine · doi:10.1017/pcm.2023.10 · Cited by 27
Metadata
- Authors
- van der Wouden, C., Cambon‐Thomsen, A., Cecchin, E., Cheung, K., Dávila‐Fajardo, C., Deneer, V., Dolžan, V, Ingelman‐Sundberg, M., Jönsson, S., Karlsson, M., Kriek, M., Mitropoulou, C., Patrinos, G., Pirmohamed, M., Samwald, M., Schaeffeler, E., Schwab, M., Steinberger, D., Stingl, J., Sunder‐Plassmann, G., Toffoli, G., Turner, R., van Rhenen, M., Swen, J., Guchelaar, H., & on behalf of the Ubiquitous Pharmacogenomics Consortium
- Venue
- Clinical Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 2017-02-13
- Volume
- 101
- Issue
- 3
- Pages
- 341-358
- ISSN
- 0009-9236 (ISSN-L)
- 1532-6535
- OpenAlex
- W2562052809
- Cited by
- 306
- References
- 62
- FWCI
- 34.06
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.